<table>
<tr>
<th>N Category</th>
<th>N Criteria</th>
</tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed</td>
</tr>
<tr>
<td>NO N1</td>
<td>No regional lymph node metastasis Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-)</td>
</tr>
<tr>
<td>N2</td>
<td>Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension, ENE(-)</td>
</tr>
<tr>
<td>N2a</td>
<td>Metastasis in single ipsilateral node 3 cm or smaller in greatest dimension and ENE(+); or a single ipsilateral node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-)</td>
</tr>
<tr>
<td>N2b</td>
<td>Metastases in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and ENE(-)</td>
</tr>
<tr>
<td>N2c N3</td>
<td>Metastases in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest dimension and ENE(-) Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral or bilateral nodes any with ENE(+); or a single contralateral node of any size and ENE (+)</td>
</tr>
<tr>
<td>N3a</td>
<td>Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-)</td>
</tr>
<tr>
<td>N3b</td>
<td>Metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral or bilateral nodes any with ENE(+); or a single contralateral node of any size and ENE (+)</td>
</tr>
</table>  
Note: A designation of "U" or "L" may be used for any N category
to indicate metastasis above the lower border of the cricoid (U) or
below the lower border of the cricoid (L)  
Similarly, clinical and pathological ENE should be recorded as
ENE(-) or ENE(+)<table>
<tr>
<td>M Category</td>
<td>M Criteria</td>
</tr>
<tr>
<td>M0</td>
<td>No distant metastasis</td>
</tr>
<tr>
<td>M1</td>
<td>Distant metastasis</td>
</tr>
</table><table>
<tr>
<th>When T is ...</th>
<th>And N is ...</th>
<th>And M is ...</th>
<th>Then the stage group is ...</th>
</tr>
<tr>
<td>Tis</td>
<td>NO</td>
<td>MO</td>
<td>0</td>
</tr>
<tr>
<td>T1</td>
<td>NO</td>
<td>MO</td>
<td>I</td>
</tr>
<tr>
<td>T2</td>
<td>NO</td>
<td>MO</td>
<td>II</td>
</tr>
<tr>
<td>T3</td>
<td>NO</td>
<td>MO</td>
<td>III</td>
</tr>
<tr>
<td>T1,2,3</td>
<td>N1</td>
<td>MO</td>
<td>III</td>
</tr>
<tr>
<td>T4a</td>
<td>N0,1</td>
<td>M0</td>
<td>IVA</td>
</tr>
<tr>
<td>T1,2,3,4a</td>
<td>N2</td>
<td>MO</td>
<td>IVA</td>
</tr>
<tr>
<td>Any T</td>
<td>N3</td>
<td>MO</td>
<td>IVB</td>
</tr>
<tr>
<td>T4b</td>
<td>Any N</td>
<td>MO</td>
<td>IVB</td>
</tr>
<tr>
<td>Any T</td>
<td>Any N</td>
<td>M1</td>
<td>IVC</td>
</tr>
</table>1\. ENE clinical (presence or absence)  
2\. ENE pathological (presence or absence)  
3\. Extent of microscopic ENE (distance of extension
from the native lymph node capsule to the farthest
point of invasion in the extranodal tissue)  
4\. Perineural invasion  
5\. Lymphovascular invasion  
6\. p16/HPV status  
7\. Performance status  
8\. Tobacco use and pack-year  
9\. Alcohol use  
10\. Depression diagnosis  
11\. Depth of invasion (mm)  
12\. Margin status (grossly involved, microscopic
involvement)  
13\. Distance of tumor (or moderate/severe dysplasia)
from closest margin  
14\. WPOI-5<table>
<tr>
<td>G</td>
<td>G Definition</td>
</tr>
<tr>
<td>GX</td>
<td>Cannot be assessed</td>
</tr>
<tr>
<td>G1</td>
<td>Well differentiated</td>
</tr>
<tr>
<td>G2</td>
<td>Moderately differentiated</td>
</tr>
<tr>
<td>G3</td>
<td>Poorly differentiated</td>
</tr>
</table>